Cingulate Inc
NASDAQ:CING
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cingulate Inc
NASDAQ:CING
|
US |
|
CH Offshore Ltd
SGX:C13
|
SG |
|
Barratt Developments P L C
LSE:BDEV
|
UK |
|
C
|
Charles Schwab Corp
F:SWG
|
US |
|
H
|
Halliburton Co
BMV:HAL
|
US |
|
S
|
Starpharma Holdings Ltd
OTC:SPHRF
|
AU |
|
S
|
S-Mac Co Ltd
KOSDAQ:097780
|
KR |
|
C
|
Century Properties Group Inc
XPHS:CPG
|
PH |
|
Gazprom Gazoraspredeleniye Rostov-Na-Donu PAO
MOEX:RTGZ
|
RU |
|
M
|
Marathon Petroleum Corp
F:MPN
|
US |
|
Takara & Company Ltd
TSE:7921
|
JP |
|
Majuba Hill Copper Corp
OTC:BFGFF
|
CA |
|
Investis Holding SA
F:IYP
|
CH |
|
P
|
Proodeftiki Technical Co SA
ATHEX:PRD
|
GR |
|
E
|
Eastern & Oriental Bhd
KLSE:E&O
|
MY |
|
V
|
Vgi Partners Ltd
ASX:VGI
|
AU |
|
S
|
S&P Global Inc
XMUN:MHL
|
US |
Bankruptcy Probability
Cingulate Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cingulate Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cingulate Inc
NASDAQ:CING
|
73.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
640B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
369.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
185.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
286.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cingulate Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cingulate Inc has total debt of 6.1m USD. This includes both short-term (6.1m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
